Table 1.
Sensitivity, % (95% CI††) | Specificity, % (95% CI) | Positive Likelihood Ratio (95% CI) | Negative Likelihood Ratio (95% CI) | AUC^ (95% CI) | |
---|---|---|---|---|---|
SBT | 95 (88–98) | 65 (61–67) | 2.7 (2.2–3.0) | 0.08 (0.03–0.2) | 0.930 (0.862–0.971) |
BAS | 95 (88–98) | 52 (48–54) | 2.0 (1.7–2.2) | 0.10 (0.03–0.3) | 0.934 (0.867–0.974) |
O3DY | 95 (85–99) | 51 (46–53) | 2.0 (1.6–2.1) | 0.10 (0.03–0.3) | N/A |
cAD8 | 83 (71–91) | 63 (55–68) | 2.2 (1.6–2.8) | 0.27 (0.1–0.5) | 0.816 (0.727–0.886) |
SBT+cAD8* | 91 (81–97) | 27 (20–30) | 1.2 (1.0–1.4) | 0.32 (0.1–0.9) | N/A |
BAS+cAD8† | 97 (90–99) | 11 (6–12) | 1.1 (0.9–1.1) | 0.27 (0.04–1.6) | N/A |
O3DY+cAD8‡ | 100 | 0 | N/A | N/A | N/A |
Abnormal SBT or abnormal cAD8.
Abnormal BAS or abnormal cAD8.
Abnormal O3DY or abnormal cAD8.
n = 102 subjects who had data for all four instruments collected.
Confidence intervals for the estimated parameters were computed based upon constant chi-square boundaries as described in Fleiss JL. Statistical Methods for Rates and Proportions. New York, NY: Wiley, 1981.
SBT = Short Blessed Test; BAS = Brief Alzheimer’s Screen; O3DY = Ottawa 3-Day-Year; AUC = area under the receiver operating characteristic curve; cAD8 = caregiver-completed Alzheimer’s Disease-8